Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry)

Autor: J, Zitouni, A-C, Bursztejn, A, Belloni Fortina, A, Beauchet, V, Di Lernia, A, Lesiak, J, Thomas, Z, Topkarci, N, Murashkin, P, Brzezinski, T, Torres, A, Chiriac, C, Luca, T, McPherson, M, Akinde, A, Maruani, R, Epishev, H, Vidaurri de la Cruz, P C, Luna, M, Amy de la Bretêque, A, Lasek, E, Bourrat, M, Bachelerie, S, Mallet, M, Steff, A, Bellissen, I, Neri, E, Zafiriou, J M P A, van den Reek, E, Sonkoly, S K, Mahil, C H, Smith, C, Flohr, H, Bachelez, E, Mahé

Publikováno v: JEADV : Journal of the European Academy of Dermatology and Venereology, 36, 11, pp. 2076-2086
JEADV : Journal of the European Academy of Dermatology and Venereology, 36, 2076-2086

Contains fulltext : 287330.pdf (Publisher’s version ) (Closed access) BACKGROUND: The COVID-19 pandemic has raised questions regarding the management of chronic skin diseases, especially in patients on systemic treatments. Data concerning the use o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::536ac2d1a979b41ec25684a02991dd1f
http://hdl.handle.net/11577/3451361